REXAHN PHARMACEUTICALS, INC. Consulting Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to the Consulting Agreement dated September 19, 2022, by and between the Company and Jay Pepose
Consulting Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2023
Third Amendment to the Consulting Agreement, dated as of January 1, 2024, by and between the Company and Jay Pepose, M.D
Consulting Agreements
REXAHN PHARMACEUTICALS, INC.
2024
Consulting Agreement between Ocuphire Pharma, Inc. and Jay Pepose, M.D., dated April 11, 2024
Consulting Agreements
REXAHN PHARMACEUTICALS, INC.
2024
Interim President and CEO Consulting Letter Agreement by and between Ocuphire Pharma, Inc. and Richard Rodgers, dated April 20, 2023
Consulting Agreements
REXAHN PHARMACEUTICALS, INC.
2023
Second Amendment to the Consulting Agreement dated December 1, 2022, by and between the Company and Jay Pepose
Consulting Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2023
Consulting Agreement between the Registrant and Jay Pepose dated April 8, 2022
Consulting Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
MI
2022
Consulting Agreement, dated February 12, 2010, by and between the Company and JFS Investments
Consulting Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
WA
2010
Consulting Agreement, dated as of August 12, 2008, between Rexahn Pharmaceuticals, Inc. and Y. Michele Kang
Consulting Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2008
Registration Rights Agreement, dated as of December 24, 2007, by and among Rexahn Pharmaceuticals, Inc. and the purchasers pursuant to the KT&G Securities Purchase Agreement, the...
Consulting Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2007